Literature DB >> 32747755

CD44 regulates epigenetic plasticity by mediating iron endocytosis.

Sebastian Müller1,2,3, Fabien Sindikubwabo1,2,3, Tatiana Cañeque1,2,3, Anne Lafon1,2,3, Antoine Versini1,2,3, Bérangère Lombard1,2,4, Damarys Loew1,2,4, Ting-Di Wu1,2,5, Christophe Ginestier6,7, Emmanuelle Charafe-Jauffret6,7, Adeline Durand1,2,8, Céline Vallot1,2,8, Sylvain Baulande1,2,9, Nicolas Servant1,10, Raphaël Rodriguez11,12,13.   

Abstract

CD44 is a transmembrane glycoprotein linked to various biological processes reliant on epigenetic plasticity, which include development, inflammation, immune responses, wound healing and cancer progression. Although it is often referred to as a cell surface marker, the functional regulatory roles of CD44 remain elusive. Here we report the discovery that CD44 mediates the endocytosis of iron-bound hyaluronates in tumorigenic cell lines, primary cancer cells and tumours. This glycan-mediated iron endocytosis mechanism is enhanced during epithelial-mesenchymal transitions, in which iron operates as a metal catalyst to demethylate repressive histone marks that govern the expression of mesenchymal genes. CD44 itself is transcriptionally regulated by nuclear iron through a positive feedback loop, which is in contrast to the negative regulation of the transferrin receptor by excess iron. Finally, we show that epigenetic plasticity can be altered by interfering with iron homeostasis using small molecules. This study reveals an alternative iron-uptake mechanism that prevails in the mesenchymal state of cells, which illuminates a central role of iron as a rate-limiting regulator of epigenetic plasticity.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32747755      PMCID: PMC7612580          DOI: 10.1038/s41557-020-0513-5

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.427


  49 in total

Review 1.  CD44: from adhesion molecules to signalling regulators.

Authors:  Helmut Ponta; Larry Sherman; Peter A Herrlich
Journal:  Nat Rev Mol Cell Biol       Date:  2003-01       Impact factor: 94.444

Review 2.  EMT: 2016.

Authors:  M Angela Nieto; Ruby Yun-Ju Huang; Rebecca A Jackson; Jean Paul Thiery
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

3.  EMT in cancer.

Authors:  Thomas Brabletz; Raghu Kalluri; M Angela Nieto; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2018-01-12       Impact factor: 60.716

4.  CD44 is the principal cell surface receptor for hyaluronate.

Authors:  A Aruffo; I Stamenkovic; M Melnick; C B Underhill; B Seed
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

Authors:  U Günthert; M Hofmann; W Rudy; S Reber; M Zöller; I Haussmann; S Matzku; A Wenzel; H Ponta; P Herrlich
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

Review 6.  CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

7.  Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells.

Authors:  Alexandra Zoltan-Jones; Lei Huang; Shibnath Ghatak; Bryan P Toole
Journal:  J Biol Chem       Date:  2003-09-03       Impact factor: 5.157

8.  Identification of the tumour transition states occurring during EMT.

Authors:  Ievgenia Pastushenko; Audrey Brisebarre; Alejandro Sifrim; Marco Fioramonti; Tatiana Revenco; Soufiane Boumahdi; Alexandra Van Keymeulen; Daniel Brown; Virginie Moers; Sophie Lemaire; Sarah De Clercq; Esmeralda Minguijón; Cédric Balsat; Youri Sokolow; Christine Dubois; Florian De Cock; Samuel Scozzaro; Federico Sopena; Angel Lanas; Nicky D'Haene; Isabelle Salmon; Jean-Christophe Marine; Thierry Voet; Panagiota A Sotiropoulou; Cédric Blanpain
Journal:  Nature       Date:  2018-04-18       Impact factor: 49.962

9.  Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis.

Authors:  Q Hua; C B Knudson; W Knudson
Journal:  J Cell Sci       Date:  1993-09       Impact factor: 5.285

10.  Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.

Authors:  A Bartolazzi; R Peach; A Aruffo; I Stamenkovic
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  28 in total

1.  Mapping Phenotypic Plasticity upon the Cancer Cell State Landscape Using Manifold Learning.

Authors:  John G Lock; Smita Krishnaswamy; Christine L Chaffer; Daniel B Burkhardt; Beatriz P San Juan
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

2.  Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer.

Authors:  Johanna M Buschhaus; Shrila Rajendran; Brock A Humphries; Alyssa C Cutter; Ayşe J Muñiz; Nicholas G Ciavattone; Alexander M Buschhaus; Tatiana Cañeque; Zeribe C Nwosu; Debashis Sahoo; Avinash S Bevoor; Yatrik M Shah; Costas A Lyssiotis; Pradipta Ghosh; Max S Wicha; Raphaël Rodriguez; Gary D Luker
Journal:  Oncogene       Date:  2022-06-22       Impact factor: 8.756

Review 3.  Organelle-specific regulation of ferroptosis.

Authors:  Xin Chen; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Cell Death Differ       Date:  2021-08-31       Impact factor: 12.067

4.  Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis.

Authors:  Yue Yang; Yuanyuan Lu; Chunhua Zhang; Qianqian Guo; Wenzhou Zhang; Ting Wang; Zhuolu Xia; Jing Liu; Xiangyu Cheng; Tao Xi; Feng Jiang; Lufeng Zheng
Journal:  Cell Mol Life Sci       Date:  2022-06-11       Impact factor: 9.207

5.  Glycolysis Dependency as a Hallmark of SF3B1-Mutated Cells.

Authors:  Raquel Vivet-Noguer; Malcy Tarin; Christine Canbezdi; Stephane Dayot; Lisseth Silva; Alexandre Houy; Sylvain Martineau; Virginie Mieulet; Géraldine Gentric; Damarys Loew; Bérangère Lombard; Fariba Nemati; Sophie Richon; Lea Guyonnet; Vincent Servois; Stephan Vagner; Marc-Henri Stern; Sergio Roman-Roman; Samar Alsafadi
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

Review 6.  Iron and Cancer: 2020 Vision.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Cancer Res       Date:  2020-09-14       Impact factor: 12.701

7.  A suppressor of dioxygenase inhibition in a yeast model of SDH deficiency.

Authors:  William Beimers; Megan Braun; Kaleb Schwinefus; Keenan Pearson; Brandon Wilbanks; Louis James Maher
Journal:  Endocr Relat Cancer       Date:  2022-05-11       Impact factor: 5.900

Review 8.  Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.

Authors:  Laura Bornes; Guillaume Belthier; Jacco van Rheenen
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

9.  Iron-Bound Lipocalin-2 Protects Renal Cell Carcinoma from Ferroptosis.

Authors:  Julia K Meier; Matthias Schnetz; Susanne Beck; Tobias Schmid; Monica Dominguez; Sanela Kalinovic; Andreas Daiber; Bernhard Brüne; Michaela Jung
Journal:  Metabolites       Date:  2021-05-19

10.  Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.

Authors:  Alicja Urbaniak; Megan R Reed; Daniel Fil; Anika Moorjani; Sarah Heflin; Michał Antoszczak; Michał Sulik; Adam Huczyński; Michalina Kupsik; Robert L Eoff; Melanie C MacNicol; Timothy C Chambers; Angus M MacNicol
Journal:  Biomed Pharmacother       Date:  2021-06-12       Impact factor: 7.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.